Tuesday, 22 April 2008

Pharma News

Mylan got Final Approval for Felodipine Extended-Release Tablets, USP
Mylan got final approval from the USFDA to market Felodipine Extended-release Tablets USP, 2.5 mg, 5 mg and 10 mg which is generic version of AstraZeneca 's Plendil Extended-release tablets.
APP Pharma got USFDA Approval for Colistimethate For Injection
APP Pharma announced that it has received approval from the USFDA to market Colistimethate for Injection, USP, 150 mg, the generic equivalent of JHP Pharmaceutical ‘s ColyMycin injection.
Bayer filed lawsuit against Sandoz and Watson
Bayer filed a patent infringement lawsuit in U.S. Federal Court in the Southern District of New York against Watson and Sandoz for the infringement of US5569652 (which covers Yasmin). Bayer has earlier lost it patent battle against Barr.
Heritage launched Nimodipine Soft Gel Capsules
Heritage Pharma announced the immediate availability of Nimodipine Soft Gelatin Capsules in 30 mg strength. Heritage's earlier received final approval of its ANDA on Nimotop on January 17, 2008

Posted by ADKS at 4:19 pm

web page statistics
Disclaimer: "IP Pharma Doc" blog is published for information purpose only. "IP Pharma Doc" blog contains no legal advice. I assume no legal responsibility for the views/information expressed here. “IP Pharma Doc” blog is my personal website and not edited by my employer, accordingly, no part of my blog should be attributed to my employer. All information on the present blog should be double checked for its accuracy and applicability. © Dr. Sarwal (2007)
 
eXTReMe Tracker